Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson & Johnson (NYSE:JNJ) is about to trade ex-dividend in the next 3 days. The ex-dividend ...
Notably, the $205 average of analysts’ price estimate for ABBV, reflects over 20% upside from its current levels of around $165. While ABBV stock may outperform JNJ stock in the next three years ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Wolfe Research has recently initiated Johnson & Johnson (JNJ) stock to Outperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on July 23, 2024, Daiwa Securities had ...